Index NDX, S&P 500 P/E 10.65 EPS (ttm) 11.57 Insider Own 2.40% Shs Outstand 386.00M Perf Week -5.56%
Market Cap 47.63B Forward P/E - EPS next Y -4.37 Insider Trans -20.08% Shs Float 346.94M Perf Month -5.79%
Income 4.78B PEG - EPS next Q -4.10 Inst Own 65.90% Short Float / Ratio 5.40% / 5.54 Perf Quarter -10.87%
Sales 15.06B P/S 3.16 EPS this Y -29.00% Inst Trans 0.89% Short Interest 18.72M Perf Half Y -31.14%
Book/sh 48.87 P/B 2.52 EPS next Y -121.80% ROA 18.70% Target Price 215.93 Perf Year -17.01%
Cash/sh 23.09 P/C 5.34 EPS next 5Y - ROE 25.90% 52W Range 115.03 - 217.25 Perf YTD -31.38%
Dividend - P/FCF 77.82 EPS past 5Y 92.10% ROI 40.60% 52W High -43.26% Beta 1.69
Dividend % - Quick Ratio 3.30 Sales past 5Y 147.90% Gross Margin 65.50% 52W Low 7.15% ATR 4.73
Employees 3900 Current Ratio 3.50 Sales Q/Q -69.30% Oper. Margin 32.10% RSI (14) 38.52 Volatility 2.86% 3.75%
Optionable Yes Debt/Eq 0.05 EPS Q/Q -97.70% Profit Margin 31.80% Rel Volume 0.65 Prev Close 124.94
Shortable Yes LT Debt/Eq 0.04 Earnings May 04 BMO Payout 0.00% Avg Volume 3.38M Price 123.26
Recom 2.40 SMA20 -3.74% SMA50 -10.28% SMA200 -19.60% Volume 2,200,367 Change -1.34%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-26-23 Initiated Guggenheim
Neutral
Mar-13-23 Upgrade TD Cowen
Market Perform → Outperform
$150 → $180
Mar-02-23 Initiated RBC Capital Mkts
Outperform
$200
Feb-24-23 Downgrade SVB Securities
Market Perform → Underperform
$111 → $93
Dec-19-22 Upgrade Jefferies
Hold → Buy
$170 → $275
Dec-14-22 Downgrade Chardan Capital Markets
Buy → Neutral
$186 → $191
Oct-21-22 Upgrade SVB Leerink
Underperform → Mkt Perform
$174 → $101
Sep-08-22 Upgrade Deutsche Bank
Hold → Buy
$165
Feb-01-22 Upgrade Redburn
Sell → Neutral
Jan-26-22 Upgrade Deutsche Bank
Sell → Hold
$175
Jan-21-22 Upgrade BofA Securities
Underperform → Neutral
$135 → $180
Jan-21-22 Initiated UBS
Neutral
$221
Dec-07-21 Initiated Cowen
Market Perform
Nov-09-21 Initiated Wolfe Research
Outperform
$304
Oct-22-21 Initiated Deutsche Bank
Sell
$250
Oct-15-21 Upgrade Piper Sandler
Neutral → Overweight
$445
Aug-06-21 Downgrade Piper Sandler
Overweight → Neutral
$246 → $445
Aug-06-21 Downgrade Oppenheimer
Outperform → Perform
Jul-15-21 Reiterated Jefferies
Hold
$170 → $250
Feb-01-21 Downgrade BofA Securities
Neutral → Underperform
Show Previous Ratings
Jun-10-23 05:39AM Jun-09-23 04:10PM 10:55AM Jun-08-23 05:50PM 02:23PM (Investor's Business Daily)
02:00PM
Loading…
02:00PM Jun-07-23 10:51AM 10:20AM 09:01AM Jun-06-23 04:55PM 11:43AM 10:42AM Jun-05-23 09:14PM 05:47PM 09:00AM
08:00AM
Loading…
08:00AM 08:00AM Jun-03-23 10:00AM Jun-02-23 03:55PM 05:30AM Jun-01-23 04:05PM 08:00AM May-31-23 09:00AM (The Wall Street Journal)
08:00AM (The Wall Street Journal)
05:30AM May-30-23 10:00AM 08:00AM 07:00AM May-26-23 04:55PM 01:36PM (The Wall Street Journal)
01:36PM
Loading…
01:36PM (The Wall Street Journal)
05:57AM 05:44AM 04:30AM (American City Business Journals)
May-25-23 08:00AM May-24-23 09:26PM 02:14PM (American City Business Journals)
11:48AM 10:16AM May-23-23 10:00AM 09:00AM 05:30AM May-22-23 11:48AM May-19-23 08:00AM 07:00AM May-18-23 10:07AM 05:30AM 05:26AM May-17-23 08:00AM May-16-23 02:00PM 06:00AM May-15-23 09:00AM 09:00AM 05:30AM May-14-23 12:00AM May-13-23 06:00AM May-12-23 10:14AM (Thomson Reuters StreetEvents)
May-11-23 02:00PM 10:23AM 04:22AM May-09-23 04:09PM 09:16AM 09:00AM May-08-23 04:52PM May-07-23 03:13PM May-06-23 10:00AM 05:30AM May-05-23 12:28PM May-04-23 07:01PM 04:05PM (Investor's Business Daily)
03:30PM 02:01PM 01:01PM 12:06PM 11:16AM 10:34AM 09:19AM (Investor's Business Daily)
09:16AM 08:05AM 06:43AM 06:40AM 06:37AM 06:30AM 06:30AM 05:57AM 04:14AM May-03-23 04:05PM (Investor's Business Daily)
04:05PM 04:00PM 11:46AM 08:34AM May-02-23 05:15PM 11:40AM 08:00AM 06:10AM May-01-23 08:20PM 05:15PM 12:40PM 07:44AM Market Digest: NLY, AJG, BXP, CAT, CMCSA, COF, DPZ, FHI, HES, IP, JNPR, SHW, URI, WM, GM, HA, ABBV, SNAP, MRNA (Argus Research)
07:44AM
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bancel Stephane Chief Executive Officer Jun 08 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 09 04:14 PM Bancel Stephane Chief Executive Officer Jun 08 Sale 124.01 40,000 4,960,364 5,411,946 Jun 09 04:14 PM Klinger Shannon Thyme Chief Legal Officer Jun 08 Sale 124.09 565 70,111 6,516 Jun 09 04:09 PM Bancel Stephane Chief Executive Officer Jun 07 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 09 04:14 PM Bancel Stephane Chief Executive Officer Jun 07 Sale 125.81 40,000 5,032,420 5,411,946 Jun 09 04:14 PM AFEYAN NOUBAR Director Jun 07 Sale 125.91 15,000 1,888,601 2,157,209 Jun 09 07:00 PM Garay Arpa Chief Commercial Officer Jun 06 Sale 125.75 2,290 287,972 2,547 Jun 07 04:05 PM Hoge Stephen President Jun 02 Sale 130.32 309 40,270 1,632,303 Jun 05 04:16 PM Klinger Shannon Thyme Chief Legal Officer Jun 02 Sale 130.32 110 14,336 5,942 Jun 05 04:20 PM Bancel Stephane Chief Executive Officer Jun 01 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer Jun 01 Sale 127.96 40,000 5,118,473 5,411,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer May 31 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer May 31 Sale 126.91 40,000 5,076,558 5,411,946 Jun 02 04:46 PM AFEYAN NOUBAR Director May 31 Sale 127.35 15,000 1,910,322 2,172,209 Jun 02 07:00 PM Hoge Stephen President May 30 Sale 124.95 1,181 147,569 1,631,961 May 31 04:21 PM Bancel Stephane Chief Executive Officer May 25 Option Exercise 0.99 40,000 39,600 5,451,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 25 Sale 127.36 40,000 5,094,421 5,411,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 24 Option Exercise 0.99 40,000 39,600 5,451,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 24 Sale 131.43 40,000 5,257,212 5,411,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 18 Option Exercise 0.99 40,000 39,600 5,451,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 18 Sale 123.77 40,000 4,950,999 5,411,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 17 Option Exercise 0.99 40,000 39,600 5,451,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 17 Sale 125.32 40,000 5,012,648 5,411,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 11 Option Exercise 0.99 40,000 39,600 5,451,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 11 Sale 127.26 40,000 5,090,486 5,411,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 10 Option Exercise 0.99 40,000 39,600 5,451,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 10 Sale 131.60 40,000 5,264,032 5,411,946 May 12 04:08 PM Hoge Stephen President May 10 Sale 133.37 250 33,344 1,630,732 May 11 04:09 PM Bancel Stephane Chief Executive Officer May 04 Option Exercise 0.99 40,000 39,600 5,451,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer May 04 Sale 135.70 40,000 5,428,125 5,411,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer May 03 Option Exercise 0.99 40,000 39,600 5,451,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer May 03 Sale 131.29 40,000 5,251,498 5,411,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer Apr 27 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 27 Sale 130.61 40,000 5,224,570 5,411,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 26 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 26 Sale 131.73 40,000 5,269,140 5,411,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 20 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 21 05:05 PM Bancel Stephane Chief Executive Officer Apr 20 Sale 142.99 40,000 5,719,540 5,411,946 Apr 21 05:05 PM Bancel Stephane Chief Executive Officer Apr 19 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 21 05:05 PM Bancel Stephane Chief Executive Officer Apr 19 Sale 142.88 40,000 5,715,262 5,411,946 Apr 21 05:05 PM Bancel Stephane Chief Executive Officer Apr 13 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 14 04:02 PM Bancel Stephane Chief Executive Officer Apr 13 Sale 160.76 40,000 6,430,340 5,411,946 Apr 14 04:02 PM Bancel Stephane Chief Executive Officer Apr 12 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 14 04:02 PM Bancel Stephane Chief Executive Officer Apr 12 Sale 156.68 40,000 6,267,335 5,411,946 Apr 14 04:02 PM Bancel Stephane Chief Executive Officer Apr 06 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 07 05:31 PM Bancel Stephane Chief Executive Officer Apr 06 Sale 157.47 40,000 6,298,950 5,411,946 Apr 07 05:31 PM Bancel Stephane Chief Executive Officer Apr 05 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 07 05:31 PM Bancel Stephane Chief Executive Officer Apr 05 Sale 154.64 40,000 6,185,585 5,411,946 Apr 07 05:31 PM Bancel Stephane Chief Executive Officer Mar 30 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 31 04:10 PM Bancel Stephane Chief Executive Officer Mar 30 Sale 148.63 40,000 5,945,054 5,411,946 Mar 31 04:10 PM Bancel Stephane Chief Executive Officer Mar 29 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 31 04:10 PM Bancel Stephane Chief Executive Officer Mar 29 Sale 148.35 40,000 5,934,076 5,411,946 Mar 31 04:10 PM Bancel Stephane Chief Executive Officer Mar 23 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 24 04:11 PM Bancel Stephane Chief Executive Officer Mar 23 Sale 149.19 40,000 5,967,683 5,411,946 Mar 24 04:11 PM Bancel Stephane Chief Executive Officer Mar 22 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 24 04:11 PM Bancel Stephane Chief Executive Officer Mar 22 Sale 150.25 40,000 6,009,804 5,411,946 Mar 24 04:11 PM Bancel Stephane Chief Executive Officer Mar 16 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 17 04:07 PM Bancel Stephane Chief Executive Officer Mar 16 Sale 150.87 40,000 6,034,724 5,411,946 Mar 17 04:07 PM Bancel Stephane Chief Executive Officer Mar 15 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 17 04:07 PM Bancel Stephane Chief Executive Officer Mar 15 Sale 148.81 40,000 5,952,499 5,411,946 Mar 17 04:07 PM Bancel Stephane Chief Executive Officer Mar 09 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 10 04:15 PM Bancel Stephane Chief Executive Officer Mar 09 Sale 139.20 40,000 5,567,859 5,411,946 Mar 10 04:15 PM Bancel Stephane Chief Executive Officer Mar 08 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 10 04:15 PM Bancel Stephane Chief Executive Officer Mar 08 Sale 141.38 40,000 5,655,310 5,411,946 Mar 10 04:15 PM Klinger Shannon Thyme Chief Legal Officer Mar 08 Sale 141.51 561 79,388 5,820 Mar 09 04:13 PM Klinger Shannon Thyme Chief Legal Officer Mar 07 Option Exercise 0.00 1,138 0 6,381 Mar 09 04:13 PM Bancel Stephane Chief Executive Officer Mar 02 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 03 04:14 PM Bancel Stephane Chief Executive Officer Mar 02 Sale 137.50 40,000 5,500,045 5,411,946 Mar 03 04:14 PM Hoge Stephen President Mar 02 Sale 136.43 1,177 160,583 1,630,460 Mar 03 04:27 PM Klinger Shannon Thyme Chief Legal Officer Mar 02 Sale 136.43 459 62,623 5,243 Mar 03 04:21 PM Bancel Stephane Chief Executive Officer Mar 01 Option Exercise 0.99 40,000 39,600 5,451,946 Mar 03 04:14 PM Klinger Shannon Thyme Chief Legal Officer Mar 01 Option Exercise 0.00 930 0 5,702 Mar 03 04:21 PM Hoge Stephen President Mar 01 Option Exercise 0.00 2,606 0 1,631,637 Mar 03 04:27 PM Bancel Stephane Chief Executive Officer Mar 01 Sale 135.18 40,000 5,407,112 5,411,946 Mar 03 04:14 PM AFEYAN NOUBAR Director Mar 01 Sale 139.00 10,000 1,390,000 2,187,209 Mar 03 07:30 PM Hoge Stephen President Mar 01 Sale 138.03 1,072 147,963 1,629,031 Mar 02 05:31 PM Hoge Stephen President Feb 28 Option Exercise 0.00 2,410 0 1,630,103 Mar 02 05:31 PM Bancel Stephane Chief Executive Officer Feb 23 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 24 04:16 PM Bancel Stephane Chief Executive Officer Feb 23 Sale 146.36 40,000 5,854,202 5,411,946 Feb 24 04:16 PM Bancel Stephane Chief Executive Officer Feb 22 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 24 04:16 PM Bancel Stephane Chief Executive Officer Feb 22 Sale 158.61 40,000 6,344,412 5,411,946 Feb 24 04:16 PM AFEYAN NOUBAR Director Feb 22 Sale 160.35 10,000 1,603,500 2,197,209 Feb 24 07:30 PM Bancel Stephane Chief Executive Officer Feb 16 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 17 04:05 PM Bancel Stephane Chief Executive Officer Feb 16 Sale 173.07 40,000 6,922,947 5,411,946 Feb 17 04:05 PM Bancel Stephane Chief Executive Officer Feb 15 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 17 04:05 PM Bancel Stephane Chief Executive Officer Feb 15 Sale 174.96 40,000 6,998,453 5,411,946 Feb 17 04:05 PM AFEYAN NOUBAR Director Feb 15 Sale 173.17 10,000 1,731,700 2,207,209 Feb 17 07:30 PM Hoge Stephen President Feb 10 Sale 163.90 245 40,156 1,627,693 Feb 13 04:14 PM Bancel Stephane Chief Executive Officer Feb 09 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 10 04:04 PM Hoge Stephen President Feb 09 Option Exercise 0.00 522 0 1,627,938 Feb 13 04:14 PM Bancel Stephane Chief Executive Officer Feb 09 Sale 165.57 40,000 6,622,894 5,411,946 Feb 10 04:04 PM Bancel Stephane Chief Executive Officer Feb 08 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 10 04:04 PM Bancel Stephane Chief Executive Officer Feb 08 Sale 166.00 40,000 6,639,983 5,411,946 Feb 10 04:04 PM AFEYAN NOUBAR Director Feb 08 Sale 167.84 20,000 3,356,761 2,217,209 Feb 10 07:30 PM Bancel Stephane Chief Executive Officer Feb 02 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 03 04:38 PM Bancel Stephane Chief Executive Officer Feb 02 Sale 174.13 40,000 6,965,310 5,411,946 Feb 03 04:38 PM Bancel Stephane Chief Executive Officer Feb 01 Option Exercise 0.99 40,000 39,600 5,451,946 Feb 03 04:38 PM Bancel Stephane Chief Executive Officer Feb 01 Sale 170.19 40,000 6,807,630 5,411,946 Feb 03 04:38 PM Bancel Stephane Chief Executive Officer Jan 26 Option Exercise 0.99 40,000 39,600 5,451,946 Jan 27 04:33 PM Bancel Stephane Chief Executive Officer Jan 26 Sale 190.67 40,000 7,626,788 5,411,946 Jan 27 04:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
